When skin is wounded or photoaged, the extracellular matrix doesn’t just passively degrade — it releases an entire library of bioactive peptide fragments that actively instruct surrounding cells on what to do next. These fragments, called matrikines, turn the dermis into a self-aware tissue capable of signaling its own repair. The discovery reframed cosmetic dermatology: peptides like GHK-Cu aren’t synthetic inventions but recreations of endogenous repair signals the body already uses.
What Are Matrikines?
Matrikines are short peptide sequences liberated from extracellular matrix (ECM) macromolecules — collagens, elastin, laminins, fibronectin — through enzymatic cleavage by matrix metalloproteinases (MMPs), elastases, and other proteases during normal turnover, wound healing, or photoaging. The term was coined by Maquart and colleagues in the late 1990s to describe the observation that fragments of ECM proteins exhibit biological activities distinct from their parent molecules.[1] Unlike intact collagen, which is largely structural, matrikines bind cell-surface receptors and trigger downstream signaling that modulates fibroblast proliferation, migration, ECM synthesis, and angiogenesis.
The best-characterized matrikine is GHK (glycyl-L-histidyl-L-lysine), a tripeptide first isolated from human plasma by Loren Pickart in 1973. Plasma levels of GHK decline with age — from approximately 200 ng/mL at age 20 to under 80 ng/mL by age 60 — paralleling the decline in dermal repair capacity.[2] GHK has high affinity for copper(II) ions, forming the complex GHK-Cu, which is the bioactive form responsible for most documented effects on skin.
How Matrikines Work
Receptor-Mediated Fibroblast Activation: Matrikines act through specific cell-surface receptors — including integrins, elastin-binding protein, and the LOX-1 receptor — to engage MAPK, PI3K/Akt, and TGF-β signaling cascades in dermal fibroblasts. The result is transcriptional reprogramming toward an anabolic, repair-oriented phenotype, with upregulation of type I and III collagen, elastin, glycosaminoglycans, and decorin.[1]
Copper Delivery via GHK-Cu: GHK functions partly as a copper-delivery vehicle. Copper is an obligate cofactor for lysyl oxidase, the enzyme that crosslinks collagen and elastin fibers to confer tensile strength. By chaperoning Cu(II) into fibroblasts at physiologic concentrations, GHK-Cu supports the biosynthetic machinery required for structurally competent ECM, while avoiding the oxidative damage caused by free copper ions.[2]
MMP Modulation: Photoaged and chronically inflamed skin shows elevated MMP-1, MMP-2, and MMP-9 activity, which degrade existing collagen faster than it can be replaced. GHK-Cu has been shown to suppress excessive MMP expression while simultaneously increasing tissue inhibitors of metalloproteinases (TIMPs), shifting the balance toward net matrix accumulation.[3]
Gene Expression Reprogramming: A 2010 genomic analysis demonstrated that GHK at picomolar to nanomolar concentrations modulates the expression of over 4,000 human genes — predominantly resetting expression toward the patterns seen in younger tissue. Affected pathways include DNA repair, antioxidant response, anti-inflammatory cytokine production, and stem cell activation.[4]
Elastin-Derived Matrikines: Distinct from GHK, fragments released from elastin degradation — particularly the VGVAPG hexapeptide — bind the elastin receptor complex on fibroblasts and keratinocytes. Depending on context, these elastokines can either promote repair or, when chronically elevated as in photoaged skin, drive a pro-inflammatory and pro-MMP phenotype that perpetuates damage.[5]
Clinical Evidence
Wound Healing: GHK-Cu has been studied in diabetic, ischemic, and surgical wounds since the 1980s. Topical application accelerates closure, increases granulation tissue formation, and improves the architecture of the regenerated dermis, with stronger and better-organized collagen bundles compared to untreated controls.[2]
Photoaging and Facial Skin: A 12-week controlled facial study of a GHK-Cu cream demonstrated significant improvements in skin laxity, clarity, density, and thickness measured by ultrasound, along with reduced fine lines compared to vehicle and to vitamin C controls.[3] Histological analysis of biopsies from chronically photodamaged forearm skin showed that GHK-Cu cream applied twice daily for 12 weeks produced statistically significant increases in dermal thickness and collagen content.
Hair Follicle Effects: Beyond dermal effects, GHK-Cu has been shown to enlarge hair follicle size and prolong the anagen growth phase in cultured human hair follicles, with effects on dermal papilla cell proliferation that parallel its actions on fibroblasts.[4]
Collagen-Derived Matrikines from Oral Supplements: Hydrolyzed collagen peptides taken orally release di- and tripeptides such as Pro-Hyp and Hyp-Gly into circulation, which have been detected at the dermal level and shown to stimulate fibroblast proliferation and hyaluronic acid synthesis in vitro — a separate but mechanistically related matrikine pathway.[1]
Safety Profile
GHK-Cu has been used in cosmetic and wound-care formulations for over three decades with a favorable safety record. Topical application at concentrations typically used in skincare (0.05–2%) shows minimal irritation potential, no significant percutaneous copper accumulation, and no reported systemic toxicity.[2] Patch testing rarely shows sensitization. Because the peptide is identical to an endogenous human sequence, immunogenicity is not expected and has not been observed.
The principal cautions are formulation-related: GHK-Cu is incompatible with certain antioxidants (notably vitamin C in acidic formulations, which can reduce Cu(II) to Cu(I) and disrupt the complex) and with strong chelators. It should be applied separately in skincare routines that include these ingredients. Elastin-derived matrikines such as VGVAPG, by contrast, are not currently used therapeutically because their chronic elevation may have pro-inflammatory effects in aged tissue.[5]
Matrikines vs Other Dermal Repair Approaches
Versus Retinoids: Topical retinoids (tretinoin, retinol) are the most evidence-based class for photoaging and act through nuclear retinoic acid receptors to upregulate procollagen and downregulate MMPs. Their mechanism is transcriptional but ligand-pharmacologic, and they are commonly limited by irritation, erythema, and photosensitivity. Matrikine peptides act through endogenous receptor systems already tuned to ECM signaling and are generally well tolerated, making them complementary rather than redundant. Combination use is common in clinical practice.
Versus Growth Factor Serums: EGF, FGF, and TGF-β-containing serums attempt to drive fibroblast activity directly, but these large proteins penetrate stratum corneum poorly and are unstable. Matrikines are small (typically 3–6 amino acids), more stable, and engineered by evolution specifically for the ECM compartment — they are arguably the more physiologic signal.
Versus Injectable Collagen Stimulators: Poly-L-lactic acid and calcium hydroxylapatite injectables stimulate neocollagenesis through a foreign-body fibrotic response. The collagen produced is structurally adequate but generated via inflammation rather than physiologic remodeling. Matrikines drive collagen synthesis along native repair pathways, though the magnitude of effect per session is far smaller.
Versus Oral Collagen Peptides: Hydrolyzed collagen supplements deliver matrikine-like fragments systemically, and randomized trials have shown improvements in skin elasticity and hydration after 8–12 weeks of daily intake. The topical and oral approaches engage overlapping but distinct fibroblast signals and can reasonably be combined.
The broader insight from matrikine biology is that ECM is not inert scaffolding. It is a depot of latent signals, and aging is in part a story of dysregulated proteolysis releasing the wrong fragments at the wrong time. Therapeutic peptides like GHK-Cu work because they reintroduce the right signal at the right concentration — closer to a hormonal replacement strategy than to a cosmetic additive.
References
- Maquart FX, et al. “Matrikines in the regulation of extracellular matrix degradation.” Biochimie. 2005;87(3-4):353-360.
- Pickart L, Margolina A. “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.” International Journal of Molecular Sciences. 2018;19(7):1987.
- Pickart L, Vasquez-Soltero JM, Margolina A. “GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.” BioMed Research International. 2015;2015:648108.
- Pickart L, Vasquez-Soltero JM, Margolina A. “The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging.” Oxidative Medicine and Cellular Longevity. 2012;2012:324832.
- Duca L, et al. “Matrix ageing and vascular impacts: focus on elastin fragmentation.” Cardiovascular Research. 2016;110(3):298-308.
